Table 2.
Injection methodology
| Treatment sessions, n (%)a (N = 639) |
|
|---|---|
| Type of anesthesia/analgesiab | |
| Intravesical instillation | 239 (37.4) |
| Local anesthetic gel | 205 (32.1) |
| General anesthesia | 173 (27.1) |
| Sedation | 117 (18.3) |
| None | 2 (0.3) |
| Type of cystoscope | |
| Rigid | 543 (85.0) |
| Flexible | 96 (15.0) |
| Injection sites used | |
| Limited to trigone vesicae | 5 (0.8) |
| Exclusions of trigone vesicae | 222 (34.7) |
| Distributed | 412 (64.5) |
| Depth of injectionb | |
| Submucosal | 538 (84.2) |
| M. detrusor vesicae | 144 (22.5) |
aPercentages are based on the total number of treatment sessions performed in all patients in the safety analysis set
bMultiple answers were possible